Darolutamide Extends Survival in Metastatic Prostate Cancer - NCI
Por um escritor misterioso
Descrição
Adding darolutamide (Nubeqa) to ADT and docetaxel improves survival in hormone-sensitive metastatic prostate cancer, results from the ARASENS trial show.
Nonmetastatic Castration-Resistant Prostate Cancer: Current
Metastatic Prostate Cancer: Investigators Ponder New Path to
Prostate cancer Nature Reviews Disease Primers
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival
Metastatic Stage 4 Prostate Cancer Treatments
Prostate Cancer Treatment (PDQ®) - NCI
Cancers, Free Full-Text
Abiraterone plus prednisone added to androgen deprivation therapy
Darolutamide is a potent androgen receptor antagonist with strong
Quick Take: Darolutamide in Advanced Prostate Cancer
A phase II study of docetaxel plus lycopene in metastatic castrate
Prostate Cancer Treatment Market Size and Share
Prostate Cancer Treatment (PDQ®) - PDQ Cancer Information
Darolutamide and Survival in Metastatic, Hormone-Sensitive
de
por adulto (o preço varia de acordo com o tamanho do grupo)
